Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
252.00
Ask:
257.00
Spread: 5.00 (1.984%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Board changes

15 Apr 2026 15:56

RNS Number : 6342A
Wilmington PLC
15 April 2026
 

15 April 2026

 

Wilmington plc

 

Board changes

 

Wilmington plc (LSE: WIL, 'Wilmington', 'the Group'), the GRC RegTech services group, today announces the appointment of three new non-executive directors who will join the board on April 28th 2026 - Christopher Humphrey joins as Senior Independent Director, Dr. Erika Schraner joins as Chair of the Remuneration Committee and Martin Rowland joins as a non-executive director. Christopher will also join the Remuneration and Audit Committees, Martin will join the Audit Committee.

 

Christopher is currently Senior Independent Director of RM plc and was Non-Executive Chair of Heywood Pension Technologies until 20 February 2026, following its acquisition by BlackRock and, until recently (20 January 2025), Chair of AIM-listed Eckoh plc, a position he held since 2017. He also served as Senior Independent Director and Audit Committee Chair at AVEVA Group plc from 2016 to 2023, Senior Independent Director and Audit Committee Chair at Videndum plc from 2013 to 2022, and non-executive director at SDL plc from 2016 to 2023. Chris has had a number of leadership roles during his career, including the position of Group Chief Executive Officer of Anite plc from 2008 to 2015.

 

Erika is currently Senior Independent Director and Chair of the Remuneration Committee at Bytes Technology Group plc, Senior Independent Director at HgCapital Trust plc and Senior Independent Director, Chair of the Nomination Committee and Chair of the Audit Committee at JTC plc. During her executive career, she spent more than 18 years working in Silicon Valley in the technology sector. She held senior professional services roles with Ernst & Young and PricewaterhouseCoopers, and an executive role at with Symantec Corporation, a global cybersecurity company. Earlier in her executive career, she held roles with IBM, REL Consultancy Group and Computer Science Corporation. Through this experience, she developed deep exposure to data and AI-enabled technologies within enterprise software. Erika earned a PhD in management science and engineering at Stanford University. Prior to her current roles, she served as a non-executive director and Chair of the Audit Committee at Videndum plc (2022-2024), non-executive director at Pod Point Group Holdings plc (2021-2025), non-executive director and Chair of the Remuneration Committee at BluJay Solutions Ltd (2021) and non-executive director and Chair of the Audit Committee at Aferian plc (2019-2022).

 

Martin is currently non-executive director and Executive Chair of Centaur Media plc and a non-executive director of Fevera plc. He was previously non-executive director and Chair of Smoove plc (2018-2023) and Chair of Inzpire Group. Prior to this, he held investment roles at LDC, the private equity fund, before moving into an advisory role with businesses.

 

Gordon Hurst, Chair of Wilmington, said

 

"I would like to welcome our three new non-executive directors to the board.  They bring immense experience of the listed company environment with significant experience across international markets, commercial development, M&A and technology."

 

The Group is making this announcement pursuant to UK Listing Rule 6.4.6R with no further disclosures necessary under UK Listing Rule 6.4.8R(1) to (6).

 

For further information, contact:

Wilmington plc

Guy Millward, CFO and Company Secretary

 

Meare Consulting

Adrian Duffield

020 7490 0049

 

 

 

07990 858548

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the UK version of Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is an international Governance, Risk and Compliance (GRC) RegTech services group providing a range of regulatory learning & training, regulation intelligence & data capabilities across the HSE (Health, Safety and ESG), legal, data privacy and financial services sectors.

 

The Group has a proprietary RegTech platform with embedded AI, employing the Model Context Protocol (MCP) to interface through an orchestration layer with its many enterprise systems. It has developed its own Autonomous Responsive Intelligence Assistant (ARIA) which enables it to connect or link, manage or automate activities across multiple data repositories, software and different AI models.

 

Wilmington employs over 1,100 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGMDDKFGVZM
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.